Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.

Journal: Cancer Cell

Published: 2020-01-13

DOI: 10.1016/j.ccell.2019.12.006

Affiliations: 24

Authors: 44

Go to article
Institutions Share
Department of Medical Oncology, DFCI, United States of America (USA) 0.24
Harvard Medical School (HMS), United States of America (USA) 0.24
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.09
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA) 0.07
Robert and Renée Belfer Center for Applied Cancer Science (The Belfer Center), DFCI, United States of America (USA) 0.05
Department of Cancer Biology, DFCI, United States of America (USA) 0.05
Harvard Department of Biological Chemistry and Molecular Pharmacology (BCMP), United States of America (USA) 0.05
Center for Functional Cancer Epigenetics (CFCE), DFCI, United States of America (USA) 0.03
Broad Institute of MIT and Harvard, United States of America (USA) 0.03
Harvard Department of Stem Cell and Regenerative Biology (HSCRB), United States of America (USA) 0.02
Boston Children's Hospital (BCH), United States of America (USA) 0.02
School of Life Sciences and Technology, Tongji University, China 0.02
Department of Pediatric Oncology, DFCI, United States of America (USA) 0.02
Harvard Department of Medicine, United States of America (USA) 0.02
Harvard Department of Pediatrics, United States of America (USA) 0.01
Blais Proteomics Center, DFCI, United States of America (USA) 0.01
Department of Oncologic Pathology, DFCI, United States of America (USA) 0.01
Department of Pathology, BWH, United States of America (USA) 0.01
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA) 0.01

Return